Ivermectin is an FDA-approved antiparasitic agent commonly used to treat various parasitic infections.
Ivermectin is an anti-parasitic agent used in the treatment of various parasitic infections. Widely relied upon for its efficacy and safety profile, it plays a vital role in managing conditions such as strongyloidiasis, onchocerciasis, and scabies — especially in immunocompromised patients
Product Detail
| Form | Tablets |
| Category | Integrative Oncology |
| Strength | 12 mg |
| Packaging | Strip of 10 tablets |
| Shelf Life | 24 months |
| Brand | Iverfit-12 |
| Manufacturer | Oncofit |
| Usage | Used to treat parasitic infections |
| Country of Origin | India |
Ivermectin Tablets USP 12mg are formulated to provide broad-spectrum anti-parasitic coverage. Though primarily used for parasitic infections, Ivermectin has also been studied in adjunctive roles for immunocompromised patients, including those undergoing cancer treatment, where secondary infections can pose serious risks.
Manufactured under strict quality control, Oncofit’s Ivermectin ensures optimal potency, bioavailability, and safety — meeting the needs of hospitals, government tenders, and global health distributors.
